← Back to Search

Primary Care Program for Breast Cancer Management

N/A

Waitlist Available

Led By Shawna V Hudson, PhD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up repeated measures at baseline, 6 months, 12 months, 18 months and 24 months

Awards & highlights

Study Summary

This trial looks at whether a program to help manage breast cancer symptoms and risks is effective.

Who is the study for?

This trial is for staff members or patients who have had breast cancer and are part of a participating practice. They must be able to speak, understand, and read English as well as provide informed consent.Check my eligibility

What is being tested?

The study is testing an organizational intervention aimed at improving the management of symptoms and risks in breast cancer survivors within primary care settings.See study design

What are the potential side effects?

Since this trial focuses on an organizational intervention rather than a medical treatment, it does not involve typical medication side effects. However, there may be indirect effects related to changes in healthcare practices.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ repeated measures at baseline, 6 months, 12 months, 18 months and 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~repeated measures at baseline, 6 months, 12 months, 18 months and 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and repeated measures at baseline, 6 months, 12 months, 18 months and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Comprehensive Breast Cancer Follow-up Care

Trial Design

2Treatment groups

Active Control

Group I: Practice Led InterventionActive Control1 Intervention

Clinic staff will participate in learning collaborative and practice facilitation as well as receive expert consultation and audit and feedback.

Group II: Standard of CareActive Control1 Intervention

No intervention.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,932,243 Total Patients Enrolled

939 Trials studying Breast Cancer

1,542,450 Patients Enrolled for Breast Cancer

Rutgers, The State University of New JerseyLead Sponsor

429 Previous Clinical Trials

63,322 Total Patients Enrolled

15 Trials studying Breast Cancer

1,000 Patients Enrolled for Breast Cancer

Shawna V Hudson, PhDPrincipal InvestigatorRutgers University

Media Library

Practice Led Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05400941 — N/A

Breast Cancer Research Study Groups: Practice Led Intervention, Standard of Care

Breast Cancer Clinical Trial 2023: Practice Led Intervention Highlights & Side Effects. Trial Name: NCT05400941 — N/A

Practice Led Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05400941 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being admitted to this scientific research trial?

"According to the info available on clinicaltrials.gov, this medical trial has stopped its recruitment process as of May 27th 2022 - despite being initially posted on December 1st 2023. Nevertheless, there are 2632 other trials recruiting patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care

Shawna V. Hudson, PhD 2024. "Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05400941.